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Matrix mechanicsHuman neural stem/progenitor cells (hNSPCs) are good candidates for treating central nervous system
(CNS) trauma since they secrete beneficial trophic factors and differentiate intomature CNS cells; however,
many cells die after transplantation. This cell death can be ameliorated by inclusion of a biomaterial scaf-
fold, making identification of optimal scaffolds for hNSPCs a critical research focus. We investigated the
properties of fibrin-based scaffolds and their effects onhNSPCs and found thatfibrin generated fromsalmon
fibrinogen and thrombin stimulates greater hNSPC proliferation than mammalian fibrin. Fibrin scaffolds
degrade over the course of a few days in vivo, so we sought to develop a novel scaffold that would retain
the beneficial properties of fibrin but degrademore slowly to provide longer support for hNSPCs.We found
combination scaffolds of salmon fibrin with interpenetrating networks (IPNs) of hyaluronic acid (HA) with
and without laminin polymerize more effectively than fibrin alone and generate compliant hydrogels
matching the physical properties of brain tissue. Furthermore, combination scaffolds support hNSPC pro-
liferation anddifferentiationwhile significantly attenuating the cell-mediated degradation seenwith fibrin
alone. HNSPCs express two fibrinogen-binding integrins,aVb1 anda5b1, and several laminin binding inte-
grins (a7b1,a6b1,a3b1) that canmediate interactionwith the scaffold. Lastly, to test the ability of scaffolds
to support vascularization,weanalyzedhuman cordblood-derived endothelial cells alone and in co-culture
with hNSPCs and found enhanced vessel formation and complexity in co-cultureswithin combination scaf-
folds. Overall, combination scaffolds of fibrin, HA, and laminin are excellent biomaterials for hNSPCs.
Statement of Significance
Interest has increased recently in the development of biomaterials as neural stem cell transplantation
scaffolds to treat central nervous system (CNS) injury since scaffolds improve survival and integration
of transplanted cells. We report here on a novel combination scaffold composed of fibrin, hyaluronic acid,
and laminin to support human neural stem/progenitor cell (hNSPC) function. This combined biomaterial
scaffold has appropriate physical properties for hNSPCs and the CNS, supports hNSPC proliferation and
differentiation, and attenuates rapid cell-mediated scaffold degradation. The hNSPCs and scaffold compo-
nents synergistically encourage new vessel formation from human endothelial cells. This work marks the
first report of a combination scaffold supporting human neural and vascular cells to encourage
vasculogenesis, and sets a benchmark for biomaterials to treat CNS injury.
 2016 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Stem cells are an important component of tissue engineering
and regenerative medicine approaches since they provide benefi-
cial secreted molecules to stimulate repair and can replace lost
cells [1]. CNS neural stem cells are multipotent stem cells capable
of self-renewal and differentiation into more committed progeni-
tors that can generate neurons, astrocytes, and oligodendrocytes
[2]. Transplanted neural stem and progenitor cells (NSPCs) migrate
to areas of injury, actively respond to the microenvironment,
secrete neuroprotective compounds, generate differentiated cells,
and improve functional recovery [3–7]. However, a significant
limitation of stem cell transplantation into the damaged CNS is
that most cells die upon injection, with reports of surviving cells
ranging from 0% to 30% at 4 weeks post-transplant for non-
immortalized human NSPCs (hNSPCs) in rodent models of ischemic
stroke [8]. The incorporation of NSPCs into a biocompatible
scaffold, which is a 3-dimensional structure that supports tissue
formation, can alleviate low cell survival post-transplant. For
example, inclusion of a scaffold increases survival of NSPCs
transplanted into rodent models of stroke [9] and traumatic brain
injury (TBI) [10]. Scaffolds provide a 2-fold increase in mouse NSPC
survival 2 weeks post-transplant into the infarct core of a mouse
stroke model [9]. Furthermore, scaffolds increase survival of mouse
NSPCs in a mouse model of TBI up to 5.6-fold at 8 weeks post-
transplant and induce significant improvements in cognitive func-
tion [10]. Thus identifying beneficial scaffolds for hNSPCs is critical
for realizing their therapeutic potential.
Three-dimensional scaffolds provide stem cells with an appro-
priate microenvironment and recapitulate the functions of native
tissue [11–13]. Thorough scaffold characterization in an in vitro
setting is essential for optimizing key parameters that support
NSPC function. This must be done prior to implementation in ani-
mal models of injury in which the in vivo niche is quite complex.
Critical scaffold attributes for NSPC transplantation into CNS tissue
[14] include non-toxic polymerization, biocompatibility with both
transplanted NSPCs and host tissue, the ability to be injected as a
liquid and polymerize in situ to form a tight apposition with the
host tissue, and mechanical properties that match that of the
CNS. The scaffold must also support vascularization to provide
nutrient delivery to cells within the scaffold, have non-toxic degra-
dation by-products and a degradation rate that allows sufficient
time for cellular integration. Extracellular matrix (ECM)
components such as proteins and polysaccharides are attractive
candidates for scaffolds since they are biocompatible, contain sites
for cellular adhesion, and provide suitable substrates for stem cell
survival, growth, and function.
Fibrin is an ECM protein involved in blood clotting during the
coagulation cascade and is non-toxic and biocompatible. Fibrin
hydrogels are formed when fibrinogen is cleaved by thrombin to
generate fibrin monomers that are covalently crosslinked by Factor
XIIIa to create a mesh, which can be degraded by the enzyme plas-
min. By varying the concentrations of fibrinogen and thrombin, the
mechanical properties and polymerization time of the hydrogel
can be modulated [15]. Fibrin contains multiple adhesive sites
including RGD sequences that engage integrins on the cell surface.
Fibrin has been used as a scaffold for mouse and human NSPCs and
as a growth factor delivery vehicle in rodent spinal cord injury
models [16–19]. Intriguingly, the source of fibrin can play an inte-
gral role in its effectiveness as a scaffold. Salmon fibrin, as opposed
to human and bovine fibrin, encourages greater neurite outgrowth
of rodent CNS neurons and better resists degradation by cellular
proteases [20,21]. Salmon fibrin matches the mechanical charac-
teristics of CNS tissue [20,22] and when used to treat rats with dor-
sal hemisection spinal cord injuries promotes greater locomotorfunctional recovery, density of serotonergic fibers caudal to the
lesion site, and recovery of bladder function than mammalian
fibrin [23]. Salmon fibrin has been developed as a human thera-
peutic and has passed numerous toxicity and immunogenicity
tests [24,25]. Although salmon fibrin is an effective scaffold to treat
CNS injury [23], it degrades rapidly in vivo (7 days) and thus is
unlikely to provide long-term support for transplanted hNSPCs.
In order to mitigate this rapid degradation, we designed combi-
nation scaffolds of fibrin and a material commonly found in the
NSPC niche within the brain, hyaluronic acid (HA) [26], which
has been shown to persist for at least 2 months when transplanted
into the CNS [27,28]. HA is a naturally occurring polysaccharide
present in the ECM that is high in the developing brain and in
the postnatal brain in regions adjacent to the lateral ventricles
where stem cells reside [26,29]. HA has been developed as a bio-
material for NSPC applications [30] including tissue repair after
acute ischemic stroke [27,28]. HA scaffolds increase the survival
of transplanted mouse NSPCs twofold, promote the differentiation
of human induced pluripotent stem cell (iPS)-derived NSPCs into
immature neurons, and reduce the host inflammatory response
when transplanted into the infarct stroke cavity of a mouse model
[9,31]. HA has advantages as a scaffold material but is not always
sufficient to promote cell adhesion [32,33], so can be combined
with adhesive peptides or another ECM component to provide cell
attachment. Thus, combination scaffolds of fibrin and HA may ben-
efit from the cell adhesive properties of fibrin and degradation rate
of HA.
Another ECM component beneficial for neural cells that can be
incorporated into scaffolds is laminin. Laminin stimulates hNSPC
expansion, migration, and differentiation [34] and can be used to
functionalize various biomaterials to encourage neural cell
adhesion in neural tissue engineering applications [35,36].
Laminin-containing collagen-based scaffolds significantly improve
the survival of mouse NSPCs 8 weeks after transplant into the trau-
matically injured mouse brain and animals treated with laminin-
containing scaffolds and NSPCs perform better in behavioral tests
than untreated controls [10]. Matrigel scaffolds, which are
predominantly collagen and laminin, seeded with embryonic stem
cell-derived hNSPCs decrease infarct volume after focal cerebral
ischemia in rats compared to cell transplants alone [37].
HA-laminin scaffolds enhance NSPC migration in response to
stromal cell-derived factor-1a (SDF-1a) gradients, which arise
from injured brain tissue [38]. Interestingly, HA in the scaffolds
leads to upregulation of the SDF-1a receptor, CXCR4, on NSPCs
while enhanced migration is dependent on both HA and laminin
in the scaffolds. Since laminin has beneficial effects on NSPCs and
hNSPCs express laminin-binding integrins [34,39], we tested
laminin in our combination scaffolds with fibrin and HA.
The biomaterial composition of the scaffold affects its vascular-
ization in vivo, which is critical for bringing nutrients to
transplanted cells. Crosstalk between endothelial cells and NSPCs
also impacts NSPC function and has inspired interest in the
in vivo neurovascular niche. Endothelial cells promote proliferation
and neuronal differentiation of rodent NSPCs in culture and slice
models, mediated at least in part through VEGF produced by
endothelial cells acting on NSPC VEGF receptors and upregulation
of genes in the Notch pathway in NSPCs [40–43]. NSPCs and
endothelial cells/vessels are closely associated in vivo, creating
neurovascular niches that can be mimicked by including both cell
types in scaffold constructs [44]. Co-transplantation of mouse
NSPCs and either mouse or bovine endothelial cells without a
scaffold into rodent stroke models leads to greater numbers of
integrated NSPCs, greater NSPC proliferation, more neuronal
differentiation, and improved functional recovery [45,46]. A poly
(ethylene glycol)-based scaffold containing mouse NSPCs and
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ter vessels than transplants of endothelial cells alone in the scaf-
fold [47]. In order to test scaffold and NSPC effects on
vasculogenesis and to incorporate components of the human neu-
rovascular niche, we added human endothelial colony-forming
cell-derived endothelial cells (hECFC-ECs) to the scaffolds. Deter-
mining optimal scaffold and cell conditions to encourage vascular-
ization in vitro may accelerate the formation of functional
vasculature after transplantation [48–50].
While fibrin and HA have been tested individually as scaffolds,
they each have limitations that may be overcome by incorporating
them into a combination scaffold. The goal of our study was to
compare fibrin and combination scaffolds to determine their mate-
rial properties, effects on hNSPCs, and potential for vascularization.
The polymerization kinetics and mechanical properties of the scaf-
folds were tested to determine whether they could be used as
injectable scaffolds and match the stiffness of CNS tissue. HNSPCs
were seeded in scaffolds to test cell proliferation and differentia-
tion and hNSPC cell surface integrins for scaffold binding were
identified. Since degradation of fibrin only scaffolds occurred
rapidly in vivo [23], the degradation of fibrin and combination scaf-
folds seeded with hNSPCs was assessed over time and at multiple
cell concentrations. Co-cultures of hNSPCs and hECFC-ECs in the
scaffolds were utilized to measure vasculogenesis as a function of
scaffold biomaterial and cellular composition and to assess poten-
tial for vascularization. These studies enabled crosstalk between
vascular endothelial cells and neural cells, creating a neurovascular
niche that affects NSPC function [42,44,51] as well as endothelial
cell behavior and vasculogenesis [47,52,53]. A comparison of fibrin
only and combination scaffolds across multiple parameters
allowed a thorough analysis of their potential use as scaffolds for
hNSPCs.2. Materials & methods
2.1. Cell culture
Fetal-derived hNSPCs (SC27 and SC23) were isolated from the
cerebral cortices of two separate brains by the National Human
Neural Stem Cell Resource and were grown as adherent cultures
on 6-well plates coated with 10 lg/mL fibronectin (human; Fisher
Scientific, Hampton, NH, USA) [54]. HNSPC basal medium included
DMEM/F12 (Fisher Scientific, Hampton, NH, USA), 20% BIT 9500
(bovine serum albumin, insulin, and transferrin; Stem Cell Tech-
nologies, Vancouver, CA), and 1% antibiotic/antimycotic (penicil
lin/streptomycin/amphotericin; Thermo Fisher Scientific, Wal-
tham, MA, USA). Proliferation media was prepared from basal
media via addition of 40 ng/mL epidermal growth factor (EGF;
PeproTech, Rocky Hill, NJ, USA), 40 ng/mL basic-fibroblast growth
factor (bFGF; PeproTech), and 20 ng/mL platelet-derived growth
factor (PDGF-AB; PeproTech,). Proliferation was measured at 3, 6,
or 7 days post cell-seeding in proliferation media. Astrocyte differ-
entiation media consisted of DMEM/F12, 20% fetal bovine serum
(FBS; Gibco, Waltham, MA, USA), and 1% antibiotic/antimycotic.
Neuronal differentiation media consisted of 96% Neurobasal
(Thermo Fisher Scientific, Waltham, MA, USA), 2% B-27 (Thermo
Fisher Scientific), 1% GlutaMAX (Thermo Fisher Scientific), and 1%
pen/strep (penicillin/streptomycin; Thermo Fisher Scientific) with
20 ng/mL brain-derived neurotrophic factor (BDNF; PeproTech),
20 ng/mL glial-derived neurotrophic factor (GDNF; PeproTech),
and 0.5 lM dibutyryl cyclic AMP (cAMP; Sigma-Aldrich, St. Louis,
MO, USA) (modified from [55]). HNSPCs were differentiated for
5 days in astrocyte differentiation media and 14 days in neuronal
differentiation media. Cells were routinely passaged 1:2 or 1:3
and seeded at 5  104–1  106 hNSPCs per 100 lL hydrogel forexperiments and equal numbers of viable cells (Trypan Blue stain-
ing) were used for each experimental group. Proliferation media
was refreshed every day (50%) for passaging and every other day
(100%) for scaffold proliferation assays to minimize mechanical
disruption of the gels with daily media changes. Differentiation
media was refreshed (100%) every other day. For co-culture exper-
iments, hNSPCs were tagged with CellTracker Green (Thermo
Fisher Scientific; C2925) at 10 lM for 45 min prior to seeding into
scaffolds.
HECFC-ECs were isolated from cord blood as previously
described with approval from UC Irvine’s Institutional Review
Board [56]. After isolation, cells were expanded on flasks coated
with 10 lg/mL fibronectin (human; Fisher Scientific) in EGM-2
media supplemented with a growth factor bullet kit (Lonza, Basel,
SUI; CC-3162). HECFC-EC were transduced with lentivirus to
express mCherry fluorescence. Lentiviral constructs (LeGO-C2)
were gifts from Boris Fehse (Addgene plasmids, Cambridge, MA,
USA; 27339). Cells were used for experiments between passages
4 and 8. All cell types were cultured in a 37 C, 5% CO2 humidified
incubator.
2.2. Hydrogel/scaffold formulation
Fibrin gels were formulated by cleaving 5 mg/mL salmon fib-
rinogen (SeaRun Holdings, Inc.) with 2 U/mL salmon thrombin
(SeaRun Holdings, Inc.) in Minimal Essential Media (MEM; Thermo
Fisher Scientific). For combination hydrogels, 1 mg/mL thiolated
Hyaluronic Acid (HA) (Glycosil; BioTime, Inc.) (average molecular
weight (MW) 250 kDa) with or without 100 lg/mL laminin
(Thermo Fisher Scientific) was included in the hydrogel mixture
prior to addition of thrombin. HA of 250 kDa MW was chosen for
these studies since HA of this size has a lower viscosity and is read-
ily modified in a reaction vessel via thiol addition to carboxylic acid
groups on the repeating HA disaccharide chain [57,58]. This thiol
modification allows for the straightforward addition of cell adhe-
sion peptides or cross-linking sites to the HA hydrogel. The MW
of this HA is within the range of sizes of HA used successfully as
scaffolds for transplantation (60 kDa–1.6 MDa) [28,31,59] and
250 kDa HA increases survival of transplanted NSPCs [9,60]. Bovine
and human fibrinogen and thrombin were obtained from Cal-
biochem or Sigma as lyophilized proteins and had endotoxin levels
less than 0.5 EU/mL. HNSPC and/or hECFC-EC cell solution was
added at a volume of 50 lL and mixed with 50 lL of hydrogel solu-
tion to create 100 lL scaffolds, cultured on 18 mm diameter cover
slips in 12-well plates.
2.3. Cell proliferation assay
The Click-iT EdU kit (Thermo Fisher Scientific) was used to iden-
tify hNSPCs entering S-phase of the cell cycle. HNSPCs were seeded
at 1  105 cells per 100 lL hydrogel and cultured in proliferation
medium supplemented with 10 lM EdU nucleoside analog at
37 C for 6 h. The scaffold constructs were fixed, permeabilized,
and blocked as previously described [34]. A copper ion (Cu1+) cat-
alyzes a covalent bond between an Alexa Fluor azide and an alkyne
in the EdU in the Click-iT reaction. All cell nuclei were stained with
4 lg/mL Hoechst 33342 in PBS. The percentage of EdU-positive
cells was determined by quantifying 3–5 randomly selected fields
from each scaffold group imaged using a Zeiss Spinning Disc Con-
focal Microscope (Zeiss, Oberkochen, DEU).
2.4. Scaffold degradation and assessment of soluble fibrinogen
Fibrin scaffold degradation and amount of soluble fibrinogen in
the media was determined using Western Blot. Briefly, 1  105,
3  105, 6  105, 1  106, or no cells were seeded in fibrin only,
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added 30 min after initial polymerization was induced with throm-
bin. In order to assess the amount of soluble fibrinogen released
from hydrogels not seeded with cells, media samples for Western
Blot were taken immediately after adding media to polymerized
hydrogels lacking cells. These were used as control samples to
determine fold changes in degradation in comparison to cell-
seeded hydrogels. After 7 or 30 days in culture in a 37 C, 5% CO2
humidified incubator, 1–5 lL of conditioned media was removed
from the well and mixed with SDS loading buffer (312 mM Tris
HCl pH 6.8, 10% SDS, 0.05% bromophenol blue, 50% glycerol, 10%
beta-mercapto ethanol). Samples were loaded in each lane of 10%
bis-acrylamide gels and transferred onto 0.2 lm nitrocellulose
membranes (BioRad). Within a single experiment, an equal amount
of media was withdrawn from each sample for analysis. Blots were
stained with Ponceau S to detect total protein. Ponceau S staining
and mouse anti-transferrin were used to verify equal loading and
transfer of each lane since transferrin is a component of the cell
culture media. The primary antibodies used were 1:50,000 dilution
of rabbit anti-salmon fibrinogen [23] and 1:1000 dilution of mouse
anti-transferrin (Abcam, Cambridge, UK; ab10208). Membranes
were incubated with primary antibodies overnight at 4 C with
gentle agitation. The following secondary antibodies were used:
goat anti-mouse HRP conjugate (Thermo Fisher Scientific; #
31430), goat anti-rabbit HRP conjugate (Pierce #31460), horse
anti-mouse AP (Vector Labs, Burlingame, CA, USA; #AP-2000).
Membranes were incubated with secondary antibodies for 1 h at
room temperature with gentle agitation and the signal was devel-
oped using Amersham ECL Prime western blotting substrate (GE
Healthcare, Scottsdale, AZ, #RPN2236) or SigmaFast BCIP/NBT
substrate (Sigma Aldrich; #B5655) for HRP or AP conjugates,
respectively. Standard curves were generated by loading a range
of 1–1000 ng of salmon fibrinogen for every experiment to accu-
rately assess linearity of protein detection and degradation within
experimental groups. ImageJ software was used to obtain quantita-
tive measurements of band intensity for comparison between
groups through the integrated density function, which sums the
values of the pixels for a given band. The integrated density values
for the bands in the standard curve for each experiment was used
to correlate the specific amount of fibrinogen released in the exper-
imental groups. It should be noted that fold change in fibrinogen
detection across conditions was used for some analyses rather than
total amount (lg) in order to control for minor variations in
scaffold degradation across experiments.
2.5. Mechanical characterization of hydrogels
Bulk rheology was used to obtain the viscoelastic properties of
the hydrogels. Elastic and viscous moduli were quantified using a
stress-controlled rheometer (Anton Paar; MCR 301, Graz, Austria)
with a 25 mm diameter parallel plate geometry. Samples contain-
ing salmon fibrinogen (5 mg/mL) alone or with HA (1 mg/mL) were
diluted in MEM and mixed with salmon thrombin (2 U/mL). The
hydrogels were prepared at a total volume of 140 lL and immedi-
ately loaded onto the rheometer upon addition of thrombin. A
humidified chamber was created via a solvent trap filled with
deionized H2O in order to prevent hydrogel evaporation during
analysis. Oscillatory measurements were taken at a frequency of
f = 1 Hz and strain of c = 1% with a height gap of 200 lm. A Peltier
temperature control system kept the chamber at 22.5 C. The
elastic (G0) and viscous (G00) moduli were recorded over a time
sweep until there was no longer a change in G0. The time sweep
was subsequently followed by a frequency sweep performed at
c = 1% from f = 0.01 to 100 Hz. At the conclusion of the frequency
sweep, a strain sweep was successively performed at f = 1 Hz from
c = 1 to 10,000%.Gel point of the hydrogels was analyzed by reducing the con-
centration of thrombin in the hydrogels to 0.15 U/mL in order to
capture polymerization kinetics. Samples were prepared as
described above and oscillatory measurements were performed
at f = 1 Hz and c = 1%. Measurements were obtained every 1 s in
order to capture the time required to transition from liquid to vis-
coelastic solid (G0 = G00).
2.6. Immunostaining and imaging
For the purposes of immunocytochemistry, scaffold constructs
were fixed with 4% paraformaldehyde for 20 min. After
4  15 min PBS washes, cells were treated with 0.3% Triton
X-100 (Sigma) in PBS for 15 min followed by 4  15 min PBS
washes. Constructs were then blocked using 10% donkey serum,
5% BSA, 0.1% Triton X-100 in PBS overnight at 4 C on a rocker.
Primary antibodies were diluted in 10% donkey serum, 5% BSA,
0.1% Triton X-100 in PBS and were incubated overnight at 4 C
on a rocker. The following primary antibodies were used: rabbit
anti-Ki67 (Leica Biosystems, Wetzlar, DEU; KI67P-CE) diluted
1:500, mouse anti-GFAP (Sigma Aldrich; G3893) diluted 1:200,
mouse anti-MAP2 (Sigma Aldrich; M4403) diluted 1:200, goat
anti-doublecortin (Santa Cruz Biotechnology, Dallas, TX, USA;
SC-8066 (c-18)) diluted 1:200. Following primary antibody incuba-
tion, scaffold constructs underwent 4  15 min PBS washes.
Secondary antibodies were diluted in 10% donkey serum, 5% BSA,
0.1% Triton X-100 in PBS and were incubated with cells for 2 h in
the dark at room temperature on a rocker. The following secondary
antibodies were used at 1:200 dilutions: donkey anti-rabbit 555
(Thermo Fisher Scientific; A-31572), donkey anti-mouse 555
(Thermo Fisher Scientific; A-31570), donkey anti-goat 488
(Thermo Fisher Scientific; A-11055). Secondary antibody incuba-
tion was followed by 4  15 min PBS washes. Cell nuclei were
counterstained with 4 lg/mL Hoechst 3342 in PBS for 5 min,
followed by 1  15 min PBS wash. Scaffolds were mounted with
20 lL Vectashield (Vector Labs; H-1000) onto cover glass and
imaged using a Zeiss Spinning Disc Confocal Microscope (Zeiss)
using a 20 or 40 objective with numerical apertures 0.8 and
0.75, respectively. Images were acquired using AxioVision Rel 4.8
software. Each individual image stack was 80 lm thick using
1.3 lm slice thickness. ImageJ was used to quantitate positively
stained cell nuclei for proliferation.
For confocal reflection microscopy, samples of the combination
and fibrin scaffolds were prepared as described in Section 2.2 on
35 mm glass bottom dishes (MatTek) and then imaged using a
reflection confocal system as previously used [61], with somemod-
ifications, to image the 3D architecture of non-labeled fibrin hydro-
gels [62]. Samples were imaged on an IX81 inverted microscope
(Olympus) equipped with a FluoView 1200 laser scanning confocal
unit (Olympus) using a 60 oil objective (PlanApo TIRFM 1.45 NA,
Olympus) and 488 nm laser (Olympus). For each sample (n = 3 per
hydrogel), 7 lm z-stacks of each hydrogel were taken with a step
size of 100 nm. Presented images were contrast enhanced for
viewing purposes.
2.7. Flow cytometry
Samples from proliferating, confluent cultures were dissociated
from the culture surface as previously described [54]. Briefly,
hNSPCs were harvested as a single cell suspension with Cell
Dissociation Buffer (Thermo Fisher Scientific), incubated and
labeled with primary antibodies for 30 min in the dark, and ana-
lyzed on an LSR II Flow Cytometer (BD Biosciences, Franklin Lakes,
NJ, USA) using a 488 nm laser. Primary antibodies used were: FITC-
labeled anti-human CD51 (anti-aV integrin, Biolegend, San Diego,
CA, USA; 327907) and isotype control FITC-labeled mouse IgG2a
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control was included alongside the stained samples and propidium
iodide was used to discern live from dead cells. Up to 10,000 events
were collected and stored electronically on the BD FACSDIVA soft-
ware. FLOWJO software was used to quantitate the percentage of
hNSPCs expressing CD51.
2.8. Vascular analysis
Quantitative analysis of vascular formation was performed
using AngioTool [63]. Images were taken with a 20 objective with
numerical aperture 0.8 on a Zeiss Spinning Disc Confocal
Microscope (Zeiss) on day 5 post-seeding and analyzed for vessel
percentage area, total number of branch points, and total vessel
length. Five randomly selected fields were obtained from each
condition for analysis.
2.9. RNA sequencing
RNA was isolated from SC27 passage 12, 15, and 17 hNSPCs
grown to confluency in single wells of 6 well plates (1–2  106
cells) using the Bio-Rad RNA Isolation Kit (Genicity, Irvine, CA,
USA; G00065). Genomic DNA contamination of all RNA samples
was assessed by using qRT-PCR for human 18S and GAPDH with
and without reverse transcriptase and found to be insignificant.
cDNA for qRT-PCR was synthesized using M-MLV reverse
transcriptase (Promega). qRT-PCR was performed using TaqMan
primers on an Abi ViiA7 qPCR machine (Applied Biosystems, Foster
City, CA, USA).
Total RNA was further monitored for quality control using the
Agilent BioanalyzerNano RNA chip andNanodrop absorbance ratios
for 260/280 nm and 260/230 nm. RNA library preparation and
sequencing was performed at the UCI Genomics Core. Library con-
struction was performed according to the Illumina TruSeq mRNA
stranded protocol. The input quantity for total RNA was 250 ng
and mRNA was enriched using oligo dT magnetic beads. The
enriched mRNA was chemically fragmented for five minutes. First
strand synthesis used random primers and reverse transcriptase to
make cDNA. After second strand synthesis, the double-stranded
cDNA was cleaned using AMPure XP beads and the cDNA was end
repaired and the 30 ends were adenylated. Illumina barcoded adap-
terswere ligated on the ends and the adapter ligated fragmentswere
enrichedbynine cycles of PCR. The resulting librarieswere validated
by qPCR and sized by Agilent Bioanalyzer DNA high sensitivity chip.
The concentrations for the libraries were normalized and the
libraries were multiplexed together. The concentration for cluster-
ing on the flowcell was 12.5 pM. The multiplexed libraries were
sequenced on one lane using single read 100 cycles chemistry for
the HiSeq 2500. The version of HiSeq control software was HCS
2.2.58 with real time analysis software, RTA 1.18.64.
For sequence mapping and bioinformatic analysis, RNA-Seq
data was processed as described previously [64]. All bioinformatics
analyses were conducted using the Galaxy platform [65]. Reads
were aligned to the human GRCh37/hg19 reference genome with
the TopHat program [66] using most default parameters.
Alignments were restricted to uniquely mapping reads with two
possible mismatches permitted. RPKM (reads per kilobase pair
per million mapped reads) were calculated as described [67] for
hg19 RefSeq genes using the SeqMonk program (http://www.
bioinformatics.babraham.ac.uk/projects/seqmonk/). MRNA RPKMs
were derived by counting exonic reads and dividing by mRNA
length. Since all samples were from a single cell type (hNSPCs),
we designated RPKM value cutoffs of above 10 (high), 1–10
(moderate), and below 1 (low) to denote expression levels of genes
of interest. As validation, highly expressed transcripts such as
beta-actin and GAPDH fall into the high category (beta-actin2247.6 ± 255.6, GAPDH 886.3 ± 105.6), as does the FGFR1
(57.45 ± 4.6) known to function in NSPCs, while FGFR2 is in the
moderate category (2.36 ± 0.7), and the muscle marker MyoD is
in the low category (0.023 ± 0.003). Factors listed as being involved
in angiogenesis were obtained from a commercial human angio-
genesis PCR array (Qiagen, Hilden, DEU) and combined with factors
previously identified by the Hughes Lab at UCI.
2.10. Statistical analysis
All statistical analyses utilized a one-way single factor ANOVA
with Tukey post hoc tests for multiple comparisons.3. Results
3.1. hNSPC proliferation in scaffolds is dependent on the species of
fibrin
Tissue engineered scaffolds for transplantation of stem cells to
aid CNS regeneration should inherently support stem cell survival
and growth. We investigated whether fibrin source influences the
proliferative capacity of cerebral cortical hNSPCs since fibrin
source significantly affects the extension of neurites from mam-
malian neurons, with longer neurites formed in salmon fibrin than
human or bovine fibrin [20].
After 6 days in culture, greater numbers of hNSPCs were present
in salmon fibrin scaffolds than in bovine or human fibrin (Fig. 1a).
Proliferation, quantified as the percentage of cells in S-phase of the
cell cycle detected by EdU incorporation, was significantly greater
for hNSPCs in salmon fibrin than cells in mammalian fibrin
(Fig. 1b). A similar trend of more proliferating hNSPCs in salmon
fibrin was detected by immunostaining for the proliferation
marker phospho-histone H3, which labels mitotic cells in
M-phase of the cell cycle (number of phospho-histone H3-
positive cells per field: salmon fibrin 15.6 ± 1.7; bovine fibrin
6.8 ± 1.0; human fibrin 9.4 ± 2.1).
3.2. Inclusion of HA increases polymerization efficiency and stiffness of
salmon fibrin scaffolds
Polymerization kinetics and mechanical strength of injectable
scaffolds are essential components of biomaterial design that can
determine the outcome of a cellular therapeutic [68]. Salmon fibrin
as a scaffold biomaterial improves locomotor functional recovery,
serotonergic innervation, and bladder recovery in spinal cord
injured rats [23], but the scaffold degrades within 1 week, which
would allow little time to support hNSPCs post-transplant. We
thus created combination scaffolds of salmon fibrin and an inter-
penetrating network (IPN) of thiolated hyaluronic acid, which has
been used previously as a scaffold for CNS transplantation
[31,60], to test whether the combined biomaterial would have dif-
ferent degradation and mechanical properties than fibrin hydro-
gels. We incorporated laminin in combination scaffolds due to its
prominent role as an ECM in the NSPC niche and because it stimu-
lates hNSPC expansion, migration, and differentiation [34,69–71].
A conventional rheometer was used to characterize the poly-
merization time of the single and combination hydrogels. The poly-
merization time, or gel point, is defined here as the time required
for the hydrogel’s storage modulus (G0) and loss modulus (G00) to be
equal. The time sweeps for the hydrogels show that fibrin/HA
reaches gel point significantly faster than fibrin alone (Fig. 2a,b).
To analyze the extent of polymerization, the amount of non-
polymerized fibrinogen associated with the different hydrogels
was assessed by collecting media for Western Blot analysis of
fibrinogen after hydrogel gelation. Initial experiments clarified
Fig. 1. Salmon fibrin encourages greater hNSPC proliferation than bovine or human
fibrin. HNSPCs (5  104) were seeded into scaffolds of salmon, bovine, or human
fibrin and cells were analyzed after 6 days. (a) More hNSPCs are present in salmon
fibrin than mammalian fibrin scaffolds (nuclei detected by Hoechst staining). (b)
EdU-incorporation reveals a higher percentage of cells in S-phase of the cell cycle in
salmon fibrin scaffolds than mammalian fibrin. P = 0.0023 (salmon vs. bovine),
P = 2.5E05 (salmon vs. human). **P < 0.01, ***P < 0.001. Error bars represent SEM.
N = 3 independent biological repeats.
Fig. 2. Increased gelation efficiency of combination hydrogels. (a) Polymerization of
fibrin hydrogels (blue) and combination fibrin/HA hydrogels (red) was measured by
oscillatory rheology. Storage modulus G0 (closed circles) and loss modulus G00 (open
circles) over time illustrate the transition of the scaffold from a liquid to gel state.
The transition occurs much more rapidly for fibrin/HA combination hydrogels. (b)
The time to gel point, defined as the time at which G0 = G00 for each hydrogel, is
approximately twice as long for fibrin (blue bar) as fibrin/HA hydrogels (red bar).
P = 0.048. (c) The amount of soluble, non-polymerized fibrinogen released into the
media approximately 30 min after the onset of polymerization of hydrogels not
seeded with cells is significantly higher for fibrin (blue bar) than combination
hydrogels (red and green bars), revealing more complete polymerization of
combination hydrogels. P = 0.048 (fibrin vs. fibrin/HA), P = 0.044 (fibrin vs. fibrin/
HA/lam). *P < 0.05. Error bars represent SEM. N = 3 independent biological repeats.
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After polymerization was complete, significantly more non-
polymerized fibrinogen was released from fibrin hydrogels thanhydrogels with HA included, while the presence of laminin in the
hydrogels had no additional effect (Fig. 2c). While there is signifi-
cantly less soluble fibrinogen remaining after polymerization of
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gen in the polymerization reaction is incorporated into the hydro-
gels in all cases. Polymerization of combination hydrogels is more
rapid and complete than fibrin hydrogels.
Since mechanical properties of the microenvironment affect
stem cells [72,73], the mechanical properties of each hydrogel were
measured using bulk rheology. The viscoelastic properties of fibrin
and fibrin/HA scaffolds were independently characterized using
conventional rheology, until G0 and G00 remained relatively stable
(Fig. 3a top). The hydrogels were initially more viscous at early time
points near polymerization (G00 > G0), but demonstratedmore elastic
behavior as gelation progressed (G0 > G00). Both G0 and G00 remained
relatively independent of frequency (Fig. 3a middle) and strain
(Fig. 3a bottom), which are hallmark characteristics of viscoelastic
materials [74,75]. Hydrogels with HA were significantly stiffer than
thoseoffibrin alone, butbothhydrogelswere less than250 Pa (fibrin
119.23 ± 16.48 Pa, fibrin/HA 202.3 ± 17.33 Pa; Fig. 3b). These
findings indicate that the bulk mechanical properties of fibrin and
combination scaffolds are within the optimal stiffness range (100–
1000 Pa) for CNS tissue and for supporting NSPC proliferation and
neuronal differentiation [76,77].
Confocal reflection microscopy was used to assess the micro-
architecture of the fibrin and combination hydrogels since the
hydrogel remains fully hydrated without fixation in this method,
thus preserving native structure [61,62]. The fibrin network was
visualized with a confocal microscope by scanning with a
488 nm laser and collecting the light reflected back from the
hydrogel. We found fibrin fibers easier to visualize in fibrin
hydrogels, while the fibrin in combination hydrogels appeared
intermixed with less reflective material (Fig. S2). HA has high
water content and thus may have a low reflective signal in confocal
reflection microscopy since a large difference in refractive index
between the material and water is required to obtain a strong
signal with this method. Hydrated HA may surround fibrin fibers
in the combination hydrogels, partially masking reflection and
inhibiting clear visualization of individual fibers.
3.3. HNSPCs proliferate and differentiate within combination scaffolds
The proliferative capacity of hNSPCs within fibrin and combina-
tion scaffolds was assessed to gauge scaffold ability to support
hNSPC function. HNSPCs proliferate similarly well in fibrin and
combination scaffolds with HA and HA/laminin, as evaluated by
Ki-67 immunostaining to detect cycling cells not in G0-phase of
the cell cycle (Fig. 4). There was a slight but not significant trend
of increased hNSPC proliferation within scaffolds that included
HA and laminin over scaffolds of fibrin alone, indicating that at a
minimum HA and laminin do not inhibit cell proliferation.
EdU-incorporation to mark proliferating cells in S-phase revealed
a matching trend in that more proliferating hNSPCs were present
in combination scaffolds than fibrin scaffolds after 7 days of culture
(EdU-positive cells in fibrin 10.74 ± 1.54%, fibrin/HA 13.55 ± 1.52%,
fibrin/HA/lam 13.62 ± 4.04%). These values are similar to those of
cells cultured on laminin-coated glass, indicating that scaffolds
enable hNSPC proliferation [78].
An important characteristic of scaffolds is the ability to promote
differentiation of transplanted stem cells since differentiated cells
may stimulate repair of the host tissue. For this reason, we inves-
tigated differentiation of hNSPCs into neurons and astrocytes
within the various scaffolds. We observed differentiation of
hNSPCs into astrocytes within fibrin, fibrin/HA, and fibrin/HA/lam
scaffolds, as assessed by immunostaining for the astrocyte marker
glial fibrillary acidic protein (GFAP) (Fig. 5a). HNSPCs also formed
neurons positive for the early neuronal marker doublecortin within
all three scaffolds (Fig. 5b). Immunostaining is not uniform
throughout the gels, making quantitative analysis of differentiatedcells impractical. Interestingly, neurite outgrowth from differenti-
ated neurons was most robust in combination scaffolds containing
laminin (Fig. 5b right). Some differentiated neurons within the
combination scaffolds were double-positive for doublecortin and
the more mature neuronal marker, microtubule-associated protein
2 (MAP2) (Fig. S3). These data indicate that combination scaffolds
can support hNSPC proliferation and differentiation, providing
rationale for their use as transplant constructs to restore injured
CNS tissue.
3.4. hNSPCs express fibrinogen- and laminin-binding integrins
The proliferation, differentiation, and elongation of hNSPCs
within scaffolds containing fibrin and laminin ECM suggest these
cells express ECM-binding integrin a and b subunits. RNA Sequenc-
ing (RNA-Seq) was utilized to determine the types of integrins
expressed by hNSPCs and indicated high levels of mRNA for b1,
a7, a3, a6, b5, aV, a5, and a9 integrins (Fig. 6a, b). These integrins
primarily bind fibrinogen (Fig. 6c), laminin, fibronectin, tenascin,
osteopontin, and vitronectin [79–81]. The only fibrinogen-
binding integrins expressed by hNSPCs at high or moderate levels
in the RNA-Seq data are aVb1 and a5b1 (Fig. 6c). In agreement
with the RNA data presented here, we previously found by flow
cytometry that hNSPCs express the a5 integrin subunit (56% pos-
itive), and also the laminin-binding integrins b1, a7, a6, and a3
[34]. However, our previous analysis did not include aV, so flow
cytometry was used to determine that 54% of the hNSPC popula-
tion expresses cell surface aV (Fig. 6d). Therefore, after using RNA-
Seq to assess expression levels of all integrins and flow cytometry
to determine cell surface expression, we conclude that hNSPCs
likely interact with fibrinogen in scaffolds through aVb1 and
a5b1 integrins and with laminin via a7b1, a6b1, a6b4, and a3b1.
Interaction of HA with cells is mediated by several receptors,
including CD44 [82], RHAMM [83], and ICAM1 [84]. However, HA
is not always sufficient for cell adhesion [32,33], and in our study
hNSPCs do not bind to HA alone but require addition of a cell adhe-
sion molecule or peptide to mediate binding (Fig. S4). We assessed
HA receptors by RNA-Seq and found the following levels of expres-
sion: CD44 (high, avg. RPKM 316.7), TLR4 (high, avg. RPKM 69.13),
RHAMM (high, avg. RPKM 16.8), layilin (low-moderate, avg. RPKM
1.69), ICAM1 (low-moderate, avg. RPKM 1.57), TLR2 (none, avg.
RPKM 0.02), lymphatic vessel endothelial hyaluronan receptor 1
(none, avg. RPKM 0.02). Thus, hNSPCs express several receptors
known to bind HA though they are not sufficient to induce
adhesion of these cells.
3.5. Hyaluronic acid slows hNSPC-mediated degradation of salmon
fibrin in vitro
Degradation kinetics is another pivotal component of biomate-
rial design that can determine the efficacy of scaffolds for
transplanted cells [68]. The inclusion of HA increased the polymer-
ization efficiency and mechanical strength of the hydrogels as
mentioned previously, so we tested whether it would affect
hNSPC-mediated scaffold degradation. Since all the scaffolds con-
tain a fibrin mesh, degradation was assessed by measuring the
release of soluble fibrinogen from the cell-seeded scaffolds after
a period of time in culture. HNSPCs were cultured in proliferating
conditions within fibrin, fibrin/HA, fibrin/HA/lam scaffolds and
degradation was measured using Western blot analysis of salmon
fibrinogen released from the scaffold into the culture media over
time (Fig. 7a).
The inclusion of HA in the scaffolds significantly reduced
hNSPC-mediated scaffold degradation (Fig. 7). After 7 days in
culture, there was approximately 7-fold more soluble fibrinogen
present in the media of the fibrin compared to fibrin/HA scaffolds
Fig. 3. Combination scaffolds are stiffer than fibrin scaffolds but both are in the stiffness range of CNS tissue. (a) Oscillatory rheology was used to gather bulk mechanical
properties of fibrin and fibrin/HA hydrogels. Storage modulus G0 (closed circles) and loss modulus G00 (closed dashes) over time illustrate the transition of the scaffold from a
liquid to gel-like state for fibrin (blue) and fibrin/HA (red) hydrogels. Storage modulus G0 (closed squares and triangles) remains greater than the loss modulus G00 (open
squares and triangles) over a broad range of frequencies and strains for both hydrogels (middle and bottom plots). (b) The maximum hydrogel stiffness measured by the
storage modulus G0 at 90 min indicates scaffolds with fibrin and HA (red bar) are significantly stiffer than those with fibrin alone (blue bar) although both are within 100–
250 Pa. P = 0.026. *P < 0.05. Error bars represent SEM. N = 3 independent biological repeats.
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tration of cells seeded within the fibrin scaffolds increased, there
was an increase in the amount of fibrinogen released into theculture media after 7 days. In contrast, higher cell concentrations
did not stimulate a significant increase in the amount of soluble
fibrinogen released from fibrin/HA scaffolds (Fig. 7c). The same
Fig. 4. HNSPCs proliferate within combination scaffolds. (a) HNSPCs (1  105) were seeded into fibrin or combination scaffolds and proliferating cells not in G0-phase of the
cell cycle were detected by immunostaining for Ki67. (b) Ki67-positive nuclei were quantified after 3 days in proliferating conditions and indicate that inclusion of HA (red
bar) and HA with laminin (green bar) is not detrimental to the hNSPCs as shown by similar proliferation of the cells in combination and fibrin scaffolds (blue bars). Error bars
represent SEM. N = 3 independent biological repeats.
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equal loading was confirmed by Ponceau S staining of all proteins
in each sample and immunoblotting for transferrin, a major pro-
tein component of the media (Figs. 7c and S5). We examined
whether cell-mediated degradation would be exacerbated at
longer time points such as 30 days, which is sufficient time for
initial hNSPC differentiation in vivo [85]. The release of soluble
fibrinogen is increased nearly 20-fold from fibrin scaffolds after
30 days relative to hydrogels without cells seeded, while the com-
bination scaffolds released less than 3-fold as much fibrinogen
(Figs. 7d and S6a). There was a significant increase in degradation
of the fibrin scaffolds from the 7 day to 30 day time points, but
strikingly this was not the case for scaffolds including HA or HA
and laminin (Fig. 7d). The inclusion of laminin did not alter the
degradation kinetics of the combination scaffolds (Fig. 7d).
Ponceau S confirmed approximately equal protein loading across
all samples (Fig. S6b).
3.6. hNSPCs and combination scaffolds increase human endothelial
cell-derived vasculogenesis
In order to create a scaffold construct that mimics the neurovas-
cular niche, promotes vascularization, and encourages synergistic
cross-talk between neural and endothelial cells, we used fibrin
alone or in combination with HA and laminin to co-culture hNSPCs
with hECFC-ECs. Scaffolds of fibrin, HA, and laminin with hNSPCs
significantly bolstered vessel formation. HECFC-EC-derived vessels
were easily visible in the scaffolds with and without hNSPCs after
5 days in culture (Fig. 8a). Quantitative analysis included vessel
area percentage and total vessel length to indicate vessel growth,
and the number of branch points as a reflection of vessel network
complexity. Fibrin/HA/lam scaffolds with both hECFC-ECs andhNSPCs yielded the highest vessel area percentage, defined as the
area of a given field occupied by vessels (Fig. 8b). These scaffolds
contained a significantly higher vessel area than fibrin with
hECFC-ECs, fibrin with co-cultured hNSPCs and hECFC-ECs, or com-
bination scaffolds with hECFC-ECs only. However, inclusion of
hNSPCs with hECFC-ECs in fibrin scaffolds showed a significantly
greater vessel area percentage than hECFC-ECs alone in fibrin,
demonstrating the marked effect of hNSPCs on vascular network
formation within the scaffolds.
Examination of total vessel length, defined as the length of the
vessels per imaged field, further confirmed the findings from vessel
area percentage. Fibrin/HA/lam and the inclusion of co-cultured
hNSPCs and hECFC-ECs significantly enhanced total vessel length
in comparison to hECFC-ECs cultured alone within fibrin or combi-
nation scaffolds (Fig. 8c). There was a significant increase in the
vessel length of co-cultured hECFC-ECs in fibrin scaffolds compared
to hECFC-ECs cultured alone in fibrin, suggesting that hNSPCs sub-
stantially affect the length of hECFC-EC-derived vessels, regardless
of biomaterial composition.
The number of vessel branch points within the scaffolds was
measured as an indicator of vascular complexity. We found that
the fibrin/HA/lam scaffolds with co-cultured hNSPCs and hECFC-
ECs contained significantly more branch points than those with
hECFC-ECs only and fibrin scaffolds with hECFC-ECs (Fig. 8d).
Indeed, there was a nearly 2-fold increase in vessel branch points
in co-cultures within combination scaffolds compared to the
hECFC-ECs cultured alone in fibrin, highlighting the synergistic
effect of both HA and laminin with hNSPCs on vascular network
complexity.
Since hNSPCs are likely affecting vasculogenesis through secre-
tion of pro-angiogenic factors, we analyzed our RNA-Seq data for
known angiogenic factors. We found that hNSPCs express high
Fig. 5. HNSPCs differentiate in combination scaffolds. hNSPCs (1  105) were differentiated in scaffolds for (a) 5 days to assess astrocytes using the marker GFAP or (b)
14 days for neurons using the marker doublecortin. Lower images in (a) and (b) reveal side view reconstructions to illustrate the three-dimensional nature of the scaffolds and
the cell extensions. HNSPCs formed astrocytes and neurons in all scaffolds, but neurite outgrowth was most pronounced in combination scaffolds containing laminin.
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increased vasculogenesis of hECFC-ECs (Fig. 8e). We grouped the
angiogenic factors into functional classes (growth factors, cytoki-
nes/chemokines, adhesion molecules/ECM, and proteases/
inhibitors) and designated cutoffs for high, moderate, and low
expression. Interestingly, a larger majority of the adhesion mole-
cule/ECM angiogenic factors and proteases and inhibitors that
modify the ECM screened for in hNSPCs were highly expressed
(71% and 55%, respectively), while only 32% of the growth factors
and 13% of the cytokines/chemokines were highly expressed
(Fig. 8f-i), emphasizing the influence the matrix has on promoting
angiogenesis. The Hughes lab previously identified SPARC
(secreted protein acidic and rich in cysteine), IGFBP7 (insulin-like
growth factor binding protein 7), collagen type 1 alpha 1, TGF-bI
(transforming growth factor b-induced protein ig-h3, Big-h3),
fibronectin 1, HGF (hepatocyte growth factor), and PCOLCE (procol-
lagen C-endopeptidase enhancer 1) secreted by stromal cells as
essential for endothelial cell sprouting or lumen formation
[86,87], and these factors are also highly expressed by hNSPCs(Fig. 8). In sum, we studied the effect of scaffold composition and
the presence of hNSPCs on the ability of hECFC-ECs to form com-
plex vessel networks and found that both play an integral role in
promoting formation of new vessels. RNA-Seq revealed that
hNSPCs express several factors involved in angiogenesis, many of
which are constituents of the ECM, that likely facilitate increased
vasculogenesis by hECFC-ECs.4. Discussion
The development of biomaterial scaffolds that provide maximal
support for hNSPC survival and function will likely improve the
ability of these cells to successfully treat the damaged CNS. We
report here on the establishment of a novel combination scaffold
incorporating salmon fibrin, HA, and laminin and the results of
multiple tests showing that the scaffold material properties, effects
on hNSPCs, degradation rate after seeding with hNSPCs, and
potential for vascularization make it a viable material for these
Fig. 6. HNSPCs express ECM-binding integrins. (a) RNA-seq analysis indicates hNSPC integrin gene expression levels from three biological replicates. Colors indicate the
log2RPKM (reads per kilobase of transcript per million mapped reads) value for each a or b integrin, with red indicating higher expression and green lower expression. (b) The
scatterplot displays average RPKM values for each integrin generated from the three replicates of hNSPCs organized from high to low expressers (error is SEM). Genes are
clustered into three categories: high (>10 RPKM), moderate (1–10 RPKM), and low (<1 RPKM) expression. Dotted lines indicate 10 RPKM and 1 RPKM boundaries. For
comparison, beta-actin, GAPDH, and FGFR1 fall in the highly expressed category, while FGFR2 is moderately expressed, and the muscle marker MyoD shows low to no
expression. (c) Integrin binding schematic illustrating a and b integrins identified as fibrinogen-binding heterodimers; lines between a and b pairs indicate heterodimers. Red
outlines denote integrins highly expressed by hNSPCs and green indicates lack of expression by hNSPCs [77]. (d) Flow cytometric analysis indicates hNSPC cell surface aV
integrin expression. Histogram of Alexa-Fluor 488-positive cells reveals a shift (54% positive cells) in hNSPCs labeled with an antibody against aV integrin compared to
IgG2A isotype control.
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fibrin in the scaffolds since it stimulates greater hNSPC prolifera-
tion than mammalian fibrin. The incorporation of HA and laminin
with salmon fibrin yields hydrogels that polymerize more effec-
tively and are slightly stiffer than fibrin alone, but ideally match
the mechanical characteristics of CNS tissue. Combination scaffolds
support the proliferation and differentiation of hNSPCs, which
express integrins that moderate binding to fibrin and laminin, indi-
cating the advantages of these materials as substrates for hNSPCs.
Combination scaffolds have a significantly slower hNSPC-mediated
degradation profile than fibrin, thus overcoming a limitation of
fibrin as a single component scaffold. Co-cultures of hNSPCs and
hECFC-ECs revealed that vessel formation and branching complex-
ity were enhanced in combination scaffolds containing both cell
types, indicating the ability of these scaffolds to support vascular-
ization. Combination scaffolds thus fulfill key criteria for hNSPC
scaffolds, including non-toxic polymerization, biocompatibility
with hNSPCs, ability to be injected as a liquid then polymerize
in situ, match the stiffness of the surrounding CNS tissue, reason-
able degradation rate, and support for vascularization.
Salmon fibrin is a more effective biomaterial than mammalian
fibrin for neuronal process extension, sprouting of human umbil-
ical vein endothelial cells (HUVECs), functional recovery in adorsal hemisection spinal cord injury model, and as shown here
proliferation of hNSPCs [20,21,23]. The differences between
salmon and mammalian fibrin may be attributed to species-
specific variations in the fibrinogen sequence. Fibrinogen is a
large glycoprotein containing pairs of three subunit chains Aa,
Bb, and c. Fibrinogen chains are heavily glycosylated, and differ-
ences in carbohydrate modifications between salmon and mam-
malian fibrinogens may underlie some of the discrepancies
between species, including variations in charge and solubility
[20,24]. The salmon genome has recently been sequenced and
comparison of the predicted amino acid sequences of salmon
and mammalian (human and bovine) fibrinogen reveals discrep-
ancies in the location of RGD sequences within the chains. The
salmon fibrinogen Aa and c chains each contain one RGD
sequence while both human and bovine Aa chains encode two
RGDs with none in the c chains. The salmon fibrinogen sequence
is much more similar in this regard to the zebrafish fibrinogen
sequence. The location differences in RGD sequences between
salmon and mammalian fibrinogen might affect binding to cell
surface integrins and in turn could be involved in differential
integrin activation, which could influence a variety of cellular
processes and explain the species-specific effects of salmon fibrin
compared to mammalian fibrin.
Fig. 7. Combination scaffolds seeded with hNSPCs degrade more slowly than fibrin scaffolds. (a) HNSPCs were seeded into fibrin only or combination scaffolds with fibrin and
HA or fibrin, HA, and laminin and degradation was assessed by measuring release of fibrinogen from the scaffold into the media by Western Blot. Intact hydrogels without
cells seeded were used as controls. (b) Fibrinogen released into the media was detected by an anti-salmon fibrinogen antibody [20]. HNSPCs (1  105) cause significantly
greater degradation of fibrin than combination scaffolds after 7 days in culture. Values are fold change in amount of fibrinogen released into the media relative to that from
fibrin/HA hydrogels without seeded cells. P = 0.032. *P < 0.05. (c) Seeding scaffolds with higher numbers of cells (1  106) leads to greater release of fibrinogen from fibrin (F)
than from fibrin/HA (F/HA) scaffolds after 7 days as detected by Western blot. Transferrin, which is a component of the media, demonstrates approximately equal loading of
media per lane. Total fibrinogen released into the media after 7 days increases when scaffolds are seeded with increasing numbers of hNSPC in fibrin scaffolds (blue bars), but
is substantially reduced by the presence of HA (red bars). Cells were seeded at 3  105, 6  105, and 1  106 cells per scaffold. P = 0.027 (fibrin vs. fibrin/HA, 3  105), P = 0.007
(fibrin vs. fibrin/HA, 6  105), P < 0.0001 (fibrin vs. fibrin/HA, 1  106), P = 0.029 (fibrin no cells vs. fibrin 1  106). *P < 0.05, **P < 0.01, ***P < 0.001. (d) Degradation induced by
hNSPCs (1  105) seeded in fibrin scaffolds (F, blue bars) increases with increasing time in culture (7 days vs. 30 days), as shown by fold change in fibrinogen released into the
media relative to that from fibrin/HA hydrogels without cells seeded. Fibrin degradation is attenuated drastically by the presence of HA (F/HA, red bars) and HA with laminin
(F/HA/Lam, green bars). P = 0.0002 (fibrin 7 days vs. fibrin 30 days), P < 0.0001 (fibrin 7 days vs. fibrin/HA 7 days), P < 0.0001 (fibrin 7 days vs. fibrin/HA/lam 7 days),
P < 0.0001 (fibrin 30 days vs. fibrin/HA 30 days), P < 0.0001 (fibrin 30 days vs. fibrin/HA/lam 30 days). ***P < 0.001. Error bars represent SEM. N = 3 independent biological
repeats.
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ization kinetics that allow the scaffold and cells to be injected as
a liquid and polymerize completely in the tissue and mechanical
properties that match the soft tissue of the brain and spinal cord.
The polymerization characteristics of the fibrin and combination
scaffolds are similar since both are controlled by thrombin and
the rate of polymerization can be modulated by adjusting the
thrombin concentration, making fibrin-based scaffolds useful for
CNS applications [16,23]. The combination scaffolds described in
this study have polymerization kinetics suitable for cell transplan-
tation and we are currently using these scaffolds with hNSPCs in an
in vivo rodent model of ischemic stroke. We injected salmon fibrinas a hydrogel for spinal cord injury [23] and are now injecting the
combination scaffold through a 30 gauge blunt tip needle into
naïve and infarcted rat striatum. By utilizing thrombin at a concen-
tration of 0.1 U/mL, we can inject 3 lL of scaffold/hNSPC solution
at 1 lL/min without experiencing premature polymerization
within the transplantation syringe. Thus, the polymerization kinet-
ics of both fibrin and combination scaffolds are suitable for
transplantation.
There was significantly less non-polymerized fibrinogen
released from the combination hydrogels than the fibrin hydrogels
30 min after the onset of polymerization, suggesting more com-
plete polymerization of the combination hydrogels (Fig. 2c). This
Fig. 8. Emulation of the human neurovascular niche within scaffolds. (a) HECFC-ECs expressing mCherry were plated at 2.5  105 cells per scaffold with or without hNSPCs
labeledwithCell TrackerGreen at 5  104 cells per scaffold. All cell nucleiwere detectedwithHoechst (blue). Neural and vascular cells interact in vitro in the scaffolds andhECFC-
ECs form early vessels after 5 days in culture. (b) Quantitative analysis of vessel area indicates a positive effect of hNSPCs on vessel formationwith additional increases in vessel
formation present in combination scaffolds of fibrin/HA/laminin (green bars) when compared to fibrin scaffolds (blue bars). P = 1.26E07 (fibrin/HA/lam – ECFC-EC + NSPC vs.
fibrin – ECFC-EC), P = 7.64E05 (fibrin/HA/lam – ECFC-EC + NSPC vs. fibrin/HA/lam – ECFC-EC), P = 0.0032 (fibrin – ECFC-EC + NSPC vs. fibrin – ECFC-EC), P = 0.0068 (fibrin/HA/
lam–ECFC-EC + NSPC vs. fibrin – ECFC-EC + NSPC). (c) Total vessel length is significantly greater in the presence of hNSPCs in both combination andfibrin scaffolds and is highest
in combination scaffolds containing both cell types. P = 2.04E06 (fibrin/HA/lam – ECFC-EC + NSPC vs. fibrin – ECFC-EC), P = 4.97E05 (fibrin/HA/lam – ECFC-EC + NSPC vs.
fibrin/HA/lam–ECFC-EC), P = 0.004 (fibrin–ECFC-EC + NSPCvs. fibrin –ECFC-EC). (d) Thenumber of vessel branchpoints is significantly enhancedby thepresence of hNSPCs and
is greatest in combination scaffolds (green bars). P = 1.09E04 (fibrin/HA/lam – ECFC-EC + NSPC vs. fibrin – ECFC-EC), P = 4.63E04 (fibrin/HA/lam – ECFC-EC + NSPC vs. fibrin/
HA/lam– ECFC-EC). **P < 0.01, ***P < 0.001. Error bars represent SEM.N = 3 independent biological repeats. (e) RNA-seq analysis indicates angiogenic factor gene expression from
three biological replicates of hNSPCs. Colors indicate the log2RPKMvalue for each factor,with red indicatinghigher expression and green lower expression (see inset for scale). (f)
A scatterplot displays average RPKM values for angiogenic growth factors generated from the three replicates of hNSPCs organized from high to low expressers (error is SEM).
Genes are clustered into three categories: high (>10 RPKM), moderate (1–10 RPKM), and low (<1 RPKM) expression. Dotted lines indicate 10 RPKM and 1 RPKM boundaries. For
comparison, beta-actin, GAPDH, and FGFR1 fall in the highly expressed category,while FGFR2 ismoderately expressed, and themusclemarkerMyoD shows low tono expression.
(g) Scatterplot of average RPKM values for cytokines and chemokines from the three hNSPC replicates. (h) Scatterplot of average RPKM values for adhesion molecules and ECM
from the three hNSPC replicates. (i) Scatterplot of average RPKM values for proteases and inhibitors from the three hNSPC replicates.
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cross-link density and subsequent polymer trapping. An estima-
tion of the distance between cross-links within the hydrogels can
be obtained by employing the equation Go = ckT, where Go is the
low frequency elastic modulus and c represents the number of
polymeric network strands per unit volume [88]. For fibrin hydro-
gels the distance between cross-links is estimated to be 32.5 nm,
while for the combination hydrogels the distance is lower at
27.3 nm due to the IPN of HA. The reduced distance between cross
links in the combination scaffolds suggest there may be increased
trapping of fibrinogen that prevents its escape during polymeriza-
tion. This finding is similar to previous work illustrating decreased
length between fiber nodes of collagen-fibrin IPN combination
scaffolds compared to those of pure collagen [89].
The reduced cross-link distance in the combination scaffolds
may be tied to substrate mechanics, which can affect NSPC differ-
entiation and thus is an important parameter to consider for NSPC
transplantation scaffolds [90]. NSPC differentiation is strongly
influenced by substrate stiffness in ranges physiologically relevant
for CNS tissue [91], such that soft substrates support neuronal dif-
ferentiation while stiffer substrates induce generation of glia
[72,73,92]. A mechanical stretch stimulus decreases NSPC differen-
tiation into oligodendrocytes when the substrate is laminin, but
not fibronectin, highlighting the importance of integrin signaling
to substrate sensing [93]. HNSPCs express a stretch-activated ion
channel, Piezo1, that responds to a variety of mechanical stimuli
and guides lineage choice towards neurons or astrocytes based
on substrate stiffness [94]. The stiffness of the fibrin and combina-
tion hydrogels used here (100–300 Pa) falls within the optimal
range for supporting neurite branching [95], NSPC differentiation
[72,73,92], and matches the compliance of human brain tissue
(100–1000 Pa) [25,91,96]. The scaffolds that include HA are
slightly stiffer than those without HA, which may be due to a com-
bination of factors including the increased cross-link density,
potential cross-linking of thiols on the HA with cysteine residues
on fibrinogen via disulfide bonding, and an increase in polymer
mass from the HA. The polymerization kinetics and mechanical
properties of combination scaffolds of fibrin and HA are optimal
for hNSPCs and CNS tissue applications.
The rate of scaffold degradation to allow for proper cellular
integration has been highlighted as an important component of
scaffold design [97]. Although there is no consensus on the ideal
residence time for an implanted scaffold, it is crucial for the scaf-
fold to remain intact long enough to promote transplanted cell sur-
vival and incorporation into the host. It should be noted that as the
scaffold degrades over time in vivo, its mechanical properties will
change, and the microenvironment of the transplanted cells will
be dominated by the host tissue rather than the scaffold. In vitro,
salmon fibrin scaffolds seeded with mouse spinal cord neurons
persist intact much longer than bovine fibrin or human fibrin scaf-
folds seeded with cells as measured by gross observation of the
scaffolds [20]. Similarly, HUVECs degrade human fibrin more
swiftly than salmon fibrin in vitro [21]. Despite salmon fibrin’s
reduced degradation in these in vitro studies, it degraded on the
order of 7 days in the more complex in vivo environment of the
injured rodent spinal cord [23], which would be too short to sup-
port the differentiation of hNSPCs in vivo, requiring a minimum
of one month. Integration of HA with salmon fibrin to create com-
bination scaffolds significantly attenuated cell-mediated fibrin
degradation while the inclusion of laminin did not further affect
degradation (Fig. 7). These findings suggest the IPN created by
HA slows fibrin degradation, which may occur by several different
mechanisms. The thiols on the HAmay cross-link with cysteines on
fibrinogen via disulfide bridges, rendering the combination scaffold
less susceptible to degradation. HA may also bind plasmin and thus
limit its diffusion. Plasmin is formed from plasminogen viaenzymes termed plasminogen activators. Plasminogen activator
expression by hNSPCs may also be reduced within the combination
scaffolds due to the presence of HA, as HA can inhibit expression of
plasminogen activator in human synovial fibroblasts [98]. Based on
our RNA-Seq data, hNSPCs express the plasminogen activators,
urokinase and tissue plasminogen activator, but do not express
plasminogen. Plasminogen is present in the fibrin hydrogels since
it co-purifies with fibrinogen [20,99]. Combining fibrin and HA to
create a composite scaffold ameliorates the rapid cell-mediated
degradation occurring with fibrin alone.
Scaffolds for hNSPCs should support basic cell functions, such as
proliferation and differentiation, which in many cases will be
mediated by binding to integrins on the cell surface. Each of the
individual scaffold components (fibrin, HA, and laminin) encourage
rodent and human NSPC proliferation in vitro and in vivo
[16,34,39,60]. Thus it is not surprising that hNSPCs proliferate
when cultured in combination scaffolds of these biomaterials
(Fig. 4), suggesting these scaffolds may aid cell survival and expan-
sion post-transplantation. Although laminin stimulated expansion
of hNSPCs in a two-dimensional system [34,39], the addition of
laminin to the combination scaffolds did not further increase
hNSPC proliferation. However, laminin may have more of an effect
on neurite outgrowth of neurons differentiated from hNSPCs
(Fig. 5b), which would fit with laminin’s long-recognized role in
the promotion of neurite outgrowth [34,100,101]. Fibrin and HA
promote differentiation in other systems as scaffolds with growth
factors support the differentiation of mouse and human NSPCs into
neurons and glia in vivo [19] and HA/polylysine multilayer films
encourage rat NSPC differentiation into neurons and glia in vitro
[102]. Interactions between cells and ECM scaffolds are mediated
by cell surface integrins [79] and hNSPCs express integrins to bind
fibrin (aVb1 and a5b1) and laminin (a7b1, a6b1, and a3b1) as
shown by RNA-Seq analysis and flow cytometry (Fig. 6) [34]
[80,81]. Combination scaffolds of fibrin and HA support hNSPCs
and these cells have cell surface fibrinogen and laminin-binding
integrins necessary for adhesion to the scaffolds.
An important characteristic of scaffolds is the ability to support
vascularization and our data indicate combination scaffolds of fib-
rin, HA, and laminin encourage the formation of vessels from
hECFC-ECs. Adding human NSPCs to hECFC-ECs within salmon
fibrin-HA-laminin scaffolds significantly increases the formation
of vascular structures (Fig. 8). Since for most measures of vessel
formation there were not significant differences between the fibrin
or combination scaffolds with hECFC-ECs alone, we conclude that
the hNSPCs have a more dominant effect on vessel generation than
the biomaterial composition. The vessels we observed from hECFC-
ECs are not fully developed vascular structures. Further vessel mat-
uration and stabilization would require the addition of perivascu-
lar cells to facilitate anastomosis and increase survival of
networks, which we plan to explore in future work. Overall, our
data indicate a strong synergistic effect of human neural stem cells
and biomaterials on the formation of human vessels.
Similar effects of NSPCs on formation of vessels from endothe-
lial cells have been described for rodent cells, but not for human
cells to our knowledge. Co-transplantation of mouse NSPCs and
mouse ES-derived vascular progenitor cells without a scaffold into
rodent stroke models leads to enhanced vessel formation in the
infarct area [46]. Mouse NSPCs induce more vessel/cord formation
from mouse brain periventricular endothelial cells when both cell
types are co-cultured on Matrigel [41]. Co-transplants of mouse
NSPCs and mouse endothelial cells in a synthetic poly(ethylene
glycol)-based scaffold implanted subcutaneously generated better
vessel formation than transplants of endothelial cells alone in the
scaffolds [47]. Using the same scaffold and cells in a rat model of
spinal cord injury, the greatest degree of vessel formation occurred
in the scaffold containing both mouse NSPCs and endothelial cells
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effects of human NSPCs on human endothelial cell vessel
formation.
The effect of hNSPCs on vasculogenesis by hECFC-ECs may be
due to neural cell secreted factors acting on the hECFC-ECs. RNA-
seq analysis of the hNSPCs shows high expression of multiple
genes relevant for vasculogenesis (Fig. 8). The vasculogenic factors
assessed in the RNA-seq data comprise a broad class of growth fac-
tors, cytokines/chemokines, adhesion molecules and ECM, and pro-
teases and inhibitors. A large percentage of the factors in the
adhesion molecule/ECM and proteases/inhibitors categories were
highly expressed (71% and 55%, respectively), suggesting that a sig-
nificant component of the effect of hNSPCs on vasculogenesis may
be mediated by modifying the ECM. In particular, hNSPCs produce
collagen I and IV, laminin, and fibronectin as well as the proteases
MMP2, MMP15, plasminogen activator (PLAU), MMP14, and the
protease inhibitors TIMP2 and TIMP1 (Fig. 8). In addition to factors
that modify the ECM, hNSPCs express high levels of the growth fac-
tors VEGF, PDGF, and TGF-b1 (Fig. 8), all of which are factors essen-
tial for angiogenesis [103–105]. Rodent NSPCs express VEGF-A
in vitro, and in vivo production of VEGF-A has been demonstrated
for mouse hippocampal NSPCs [106–108]. Human NSPCs trans-
planted into a rodent stroke model promote behavioral recovery
and neovascularization, and both of these effects are lost if VEGF
is blocked with a human VEGF-specific antibody [109]. Here, we
add to these findings by providing direct evidence of VEGF-A and
VEGF-B mRNA production by hNSPCs. We showed previously that
the growth factors TGF-a, HGF, and the ECM molecule fibronectin,
all of which are expressed by hNSPCs, are secreted by fibroblasts
and contribute to angiogenic sprouting from endothelial cells
[86,87]. Intriguingly, hNSPCs also express elevated levels of SPARC,
IGFBP7, collagen I, TGF-bI (big-h3), and moderate levels of PCOLCE,
each of which the Hughes lab found to be required for endothelial
cell lumen formation, which relates to vessel formation and matu-
ration [86]. These data suggest that factors produced by the
hNSPCs are likely playing a key role in increasing vasculogenesis
in co-cultures with hECFC-ECs, highlighting the relevance of cross-
talk between neural and endothelial cells for vascularization.
Interest in the use of scaffolds containing multiple components
is growing in the fields of tissue engineering and regenerative
medicine. Scaffolds combining fibrin and hyaluronic acid induce
greater chondrogenesis of human bone marrow-derived mes-
enchymal stem cells (BMSCs) in vitro than fibrin scaffolds [110].
Human MSCs and human umbilical vein endothelial cells
(HUVECs) were plated in scaffolds of fibrin or collagen/fibrin com-
binations at different mass ratios to assess vascularization [111]. In
this case, the ratio of components in the combination scaffold
played a key role in its effect on cells. Vessel formation was best
in either fibrin or combination scaffolds at a mass ratio of 40/60
(collagen/fibrin); notably the individual and combinations scaf-
folds were of similar stiffness with combination scaffolds having
more robust polymerization kinetics than those of fibrin alone.
MSCs coalesced along vessels in the 40/60 combination scaffolds,
but specific effects of the scaffold on MSCs were not assessed. Com-
bination scaffolds have been utilized to provide a localized source
of therapeutic molecules, as fibrin-HA IPNs loaded with SDF-1a
promote homing of chondrogenic progenitor cells and subsequent
functional repair of bovine cartilage [112]. In regards to NSPCs, HA-
collagen scaffolds increase mouse NSPC survival when trans-
planted into the infarct core of stroke-injured mice [9]. Our study
now identifies combination scaffolds of fibrin-HA-laminin as ben-
eficial scaffolds for human NSPCs since they resist rapid degrada-
tion, enhance vascularization by hECFC-ECs, and support hNSPC
proliferation and differentiation. Based on the promising results
to date with combination scaffolds, more research is clearly war-
ranted to test the effects of a variety of combination scaffolds onhuman NSPCs as these cells move toward use in clinical
applications.
5. Conclusions
Our data indicate that combination scaffolds consisting of sal-
mon fibrin with HA and laminin possess material properties that
enable polymerization with cells, mimic native brain tissue, sup-
port hNSPC function, and better resist degradation than fibrin
alone. Furthermore, hNSPCs work synergistically with combination
scaffolds to enhance vasculogenesis from hECFC-ECs, thus provid-
ing motivation for their use to create vascularized transplant scaf-
fold constructs to treat human disease. Our findings offer
implications for the use of more complex neural tissue engineering
strategies utilizing multiple human cell types and scaffold bioma-
terials to enhance cellular function in vitro and in vivo. Employ-
ment of more sophisticated methods such as combination
scaffolds to increase stem cell survival and function post-
transplant will be critical for their use as cellular therapeutics.
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